News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

Toca5: A Phase 2/3 Randomized, Open Label Study of Toca 511™, a Retroviral Replicating Vector, Combined With Toca FC™ versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma

Al's Comment:

 The Tocagen trial has just opened!  Our website and clinicaltrials.gov do not have the details yet, but if you are interested in this trial, call them and ask where it is being done.  This is for people with recurrent GBM or Anaplastic Astrocytoma, who are going to have surgery.  There is a video on how this works at http://www.tocagen.com/toca5/

 This is one of my favorite new trials.  (Disclaimer: Tocagen is a sponsor of the Musella Foundation)


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.tocagen.com/toca5/


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740